Background: The novel urinary neutrophil gelatinase-associated lipocalin (uNGAL) is an early and highly predictive biomarker that is rapidly released in acute kidney injury (AKI).
Introduction
Acute kidney injury (AKI) is a common complication within critically ill patients, affecting about 25% of all intensive care unit (ICU) admissions. Among these patients, circulatory shock is thought to be the most common contributing factor to AKI and is associated with high mortality rates of 40-50% [1, 2] .
Interestingly, the mortality from AKI complicating circulatory shock has not changed markedly over the years, mainly because of the late diagnosis, lack of sensitivity and specificity of the current AKI biomarkers and the lack of effectiveness of the new therapies [2] [3] [4] [5] .
Currently, AKI is routinely diagnosed and followed up by measuring serum creatinine concentration. Although it has been widely used for the assessment of glomerular filtration rate (GFR), it has poor sensitivity and specificity in AKI, as it lags behind both renal injury and renal recovery [6] . It does not directly reflect the kidney cell injury, but rather the delayed functional consequences of the damage after >50% loss of the kidney function [7, 8] . So, an early detection of adult patients with kidney injury would provide an opportunity to treat and prevent the extension of kidney injury before the serum creatinine rises [9] .
Recent studies have proposed many biomarkers for the early detection of AKI, which may facilitate earlier diagnosis and proper management resulting in fewer complications and improved outcomes [10, 11] .
Neutrophil gelatinase-associated lipocalin (NGAL) appears to be the most promising of all biomarkers [11] . NGAL was originally purified as a 25 kDa protein covalently bound to gelatinase from neutrophils which is normally expressed at very low levels in several human tissues, including the kidneys, lungs, stomach, and colon [12, 13] . NGAL protein is also rapidly and massively induced in kidney tubule cells soon after renal ischemia [14] .
Urinary-NGAL (uNGAL) is probably more reflective than plasma-NGAL for evaluation of the local renal injury [15] . It rapidly accumulates within hours in the kidney tubules and urine after nephrotoxic or ischemic insults [16] , and represents an early predictive biomarker for the development of AKI 1-3 days earlier than the serum creatinine [10] . In contrast to the plasma-NGAL, uNGAL is not elevated in septic patients without AKI [17] .
Based on the available studies, the use of uNGAL as a marker of septic AKI is promising but requires further investigation. In particular, the relationship between uNGAL expression, plasma-NGAL and renal inflammation requires additional clarification. However, few studies have specifically addressed the issue of expression of uNGAL in renal tissues during sepsis, but never in circulatory shock.
The purpose of this study is to investigate the pattern of uNGAL level in AKI as an early diagnostic and prognostic biomarker and to explore the relationship with the other conventional renal biomarkers, in patients with circulatory shock.
Materials and methods
This study was conducted on 45 Egyptian patients admitted to ICU of the Department of Critical Care Medicine, Cairo University Hospitals, Al Haram hospital (Ministry of Health Hospital) and Al Salam hospital (private hospital), from October 2010 to May 2011 with circulatory shock. All patients were enrolled in the study and followed up, only during their stay in ICU.
This study was approved by the Ethics Committee Review Board of the Faculty of Medicine, Cairo University. Informed written consent was acquired from each patient before the enrollment in the study.
Thirty-four patients (19 males) did not show any response to fluid ± vasopressor therapy and were considered as the patients' group, and 11 patients (8 males) showed an early response to fluid ± vasopressor therapy and were considered as the control group; mean age: 45.6 ± 17.4 (15-75) years for the patients and 48.5 ± 14.2 (26-69) years for the controls, P = NS.
All subjects were enrolled in the study within 6 h from the diagnosis of circulatory shock with normal kidney functions, and followed up consecutively for 4 days during their stay in ICU.
Inclusion criteria
Patients presented with circulatory shock during their ICU stay; diagnosed on the basis of the Empiric Criteria of Circulatory Shock [18] , which requires 4 out of the following: 1) Ill Appearing or altered mental status. 2) Heart rate >100 beat/min. 3) Respiratory rate >22/min, or paCO 2 <32 mmHg. 4) Arterial hypotension (systolic blood pressure 690 mmHg or mean arterial blood pressure 670 mmHg), for >20 min duration. 5) Urine output <0.5 mL/kg/h. 6) Arterial base deficit <À5 mEq/L. (1) Acute kidney injury (AKI) staging was done using the acute kidney injury network criteria (AKIN) [20] ( Table 1 ): (2) Detection of uNGAL using ELISA at day 1 (during the first 6 h of the patient enrollment):
Urine samples were aseptically collected and voided directly into a sterile container. Centrifugation of the urine samples at 1000· for 15 min is performed to remove the particulate matter and the supernatant then the aliquot stored at À20°C. Repeated freeze-thaw cycles were avoided which may cause erroneous results [12] . Urinary-NGAL was analyzed by the commercially available Enzyme Linked Immunosorbent Assay (ELISA) kits (Biovender Laboratorni Medicina, Czech Republic) and performed as previously described [21] ; briefly, it is a sandwich monoclonal ELISA procedure determining uNGAL in human urine. Microtiter plates coated with monoclonal antibodies against human uNGAL were coated with samples or standards (uNGAL concentrations ranging from 1 to 1000 lg/L), which were read at 450 nm with a microplate reader. All tests were performed according to the manufacturers' instructions.
(1) For follow up, all patients were subjected to:
Full clinical evaluation every 2 h.
(1) Detection of uNGAL using ELISA at day 2:
Urine samples were obtained to test uNGAL only at day 1 and day 2, as it represents an early predictive biomarker for the development of AKI 1-3 days earlier than serum creatinine [10] .
(1) Measurement of the routine laboratory investigations;
including blood urea and serum creatinine and estimation of GFR was done at days 2, 3 and 4.
Statistical methods
Data were collected and verified before computerized data entry using the Statistical Package for Social Sciences (SPSS) version 15.0. The data were summarized using descriptive statistics; including means ± standard deviations. Statistical differences between groups were tested using the Chi-square test for qualitative variables, the independent sample t-test and the one-way ANOVA (analysis of variance) with the Bonferroni post hoc test for quantitative normally distributed variables, while the nonparametric Mann-Whitney test and the Kruskal-Wallis test were used for quantitative variables which are not normally distributed. Spearman's correlation was done to test for linear relations between variables. Recessive-Operating Characteristic Curve (ROC) was used to test for the efficiency of uNGAL in predicting acute kidney injury and mortality. P-values 60.05 were considered statistically significant while 60.001 were considered highly statistically significant. Tests of performance were evaluated by measurement of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and the diagnostic accuracy.
Results
At day 1, the clinical and biochemistry data of both groups, were comparable including age, sex, number of diabetics, number of patients with disturbed conscious level and urine output. Only, the base deficit showed significant lower values in the patients' group compared to the controls. Both the ICU stay days and number of deaths were significantly higher in the patients' group rather than the controls ( Table 2 ). Compared to the controls, all renal function tests of the patients showed significantly higher values at all days except at day 1 which showed comparable values to the controls (Fig. 1 ). The only exception was uNGAL which showed significantly higher values at day 1 in the patients' group compared to the controls (Table 3) . Significantly incremental values of uNGAL were detected in the patients' group, with the reduction of the urine output from polyuria to oliguria. On the contrary, no difference was detected in the control group (Table 4) . Significant inverse correlations could be detected between UOP and uNGAL at both days 1 and 2 (r = À0.41, P < 0.05, and r = À0.64, P < 0.001, respectively). AKINscore showed a significant correlation with uNGAL but only at day 2 (r = 0.46, P < 0.05), otherwise no significant correlation could be detected between uNGAL and the other kidney function tests.
Prediction of acute kidney injury using uNGAL
Urinary-NGAL values at days 1 and 2 to AKIN-score estimated at day 1 showed a bad early prediction of AKI (area under curves were 0.52 and 0.44, P = NS and NS, respectively).
But for uNGAL values at days 1 and 2 to AKIN-score estimated at day 2, the results showed a good early prediction of AKI (area under curves were 0.74 and 0.71, P < 0.05 and <0.05, respectively) ( Fig. 2) .
Also, uNGAL values at days 1 and 2 to AKIN-score estimated at day 3 showed a good early prediction of AKI (area under curves were 0.81 and 0.84, P < 0.001 and <0.001, respectively) (Fig. 2) . The same could be detected at days 1 and 2 to AKIN-score estimated at day 4, the results showed a good early prediction of AKI (area under curves were 0.72 and 0.84, P < 0.001 and <0.001, respectively).
For prediction of AKIN, the best cutoff point at day 1 was 26 ng/mL and at day 2 was 29 ng/mL, respectively ( Table 5 ).
Prediction of mortality complicating acute kidney injury using uNGAL
Compared to the controls, significantly higher mortality rate could be detected in the patients' group. Three patients (8.8%) survived compared to 7 (63.6%) of controls (P < 0.001). Thirty-one patients (91.2%) died compared to 4 (36.4%) controls (P < 0.001). But the ICU stay in days was comparable between the patients and the controls; the survivors stayed for 6 ± 2.6 (4-9) days compared to 8.5 ± 6.3 (3-21) days for the controls (P = NS), and those who died Early expression of urinary neutrophil gelatinase-associated lipocalin biomarker predicts acute kidney stayed for 4 ± 2.5 (2-16) days compared to 8.7 ± 5.5 (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) days for the controls (P = NS). Compared to the survivors, only at day 2 the non survivors showed significantly higher uNGAL values in both groups. At day 1 uNGAL values were 40.8 ± 49.8(4-135) (ng/mL) in the survivors, compared to 43.4 ± 26.4 (6-100) in the non survivors (P = NS), but at day 2 uNGAL value was 14 ± 9 (2.9-30) (ng/mL) in the survivors, compared to 52.5 ± 32.9 (2.5-130) in those who died (P < 0.001), respectively.
Only at day 2, uNGAL values detected at days 1 and 2 could predict the mortality complicating acute kidney injury and showed a good early prediction (area under curves were 0.65 and 0.86, and P < 0.05 and <0.001, respectively).
The best cutoff value was 29 ng/mL and 32 ng/mL at days 1 and 2, respectively ( Table 6 ).
Discussion
Recent advances in the early stress response of renal tubule cells to ischemic injury have provided several novel biomarkers for AKI facilitating earlier diagnosis, proper management and fewer complications improving the final outcomes [10, 21] .
An ideal urinary biomarker in AKI should have several characteristics, including reliable detection of AKI; being sufficiently sensitive to detect early subclinical injury; reflecting the location of kidney injury; reflecting time dependent changes in the severity of injury, and being simple, cheap and easy to be measured. It is generally accepted that no single biomarker will perform sufficiently to stand alone as a diagnostic, injury severity, and prognostic marker [22] .
The neutrophil gelatinase associated lipocalin (NGAL), possibly is the most promising AKI biomarker in ICU settings preceding a rise in serum creatinine by several hours to days [21] . It is easily detectable in the blood and urine soon after ischemic or nephrotoxic kidney injury [23] . Both serum and uNGAL (uNGAL) have been found to be reliable predictors of AKI [11] , but uNGAL is more sensitive and specific than plasma-NGAL and is rapidly released after kidney injury [24] .
Compared to the controls, in our study the uNGAL values at day 1 were significantly higher in the patients' group (52.2 ± 31.5 and 13.7 ± 9.2 respectively; P < 0.001) and at day 2 (51.9 ± 32.7 and 15.7 ± 16.6, respectively; P < 0.001). Compared to our controls, the conventional kidney function tests showed significantly higher values in the patients' group at all days except at day 1, but the values of uNGAL were significantly higher even at day 1. This is in agreement with Mori et al., who studied cross sectional ICU patients with AKI and found a >10-fold increase in plasma-NGAL and a >100-fold increase in uNGAL compared to their control group [25] .
In our study, significantly increased values of uNGAL at days 1 and 2 were detected in the patients' group, with reduction of the urine output (P < 0.05 and <0.001). We also found good inverse correlations between UOP and uNGAL at both days 1 and 2. AKI score showed also a good correlation with uNGAL only at day 2; otherwise no correlation could be detected between uNGAL and the other kidney function tests; including blood urea, serum creatinine and GFR.
Conversely Mori et al., found that both plasma and uN-GAL correlated strongly with serum creatinine levels [25] . These findings were in disagreement with our study and may be explained by the fact that, this study was conducted on patients with already established renal failure, while in our study, the patients with circulatory shock were in a much earlier phase. There are rapidly evolving and devolving stages of AKI and variable kidney response to fluid ± vasopressors according to initial resuscitation management strategy [25] .
Also, in a recent study conducted on 92 patients by Wagener et al., it was shown that uNGAL/urine creatinine ratio 3 h after liver transplantation is a very good marker of AKI in all patients. The ROC curves of uNGAL/urine creatinine ratio to predict AKI were 0.8 (P < 0.001) at 3 h, and 0.64 (P < 0.05) at 18 h after reperfusion [24] .
It is important to realize that, the temporal association of urinary biomarker expression in relation to the rapidly evolving and devolving stages of AKI, including initiation, extension, maintenance, and recovery may have different biomarker cutoff levels for detection of AKI [26] .
To the best of our knowledge, our study is the first to investigate whether uNGAL can predict AKI complicating circulatory shock (ischemic injury) in ICU patients. In our study, the results of uNGAL values at days 1 and 2 to AKIN diagnosed at days 2, 3 and 4 showed a good early prediction of AKI, with the best cutoff point of 26 ng/mL at day 1 and 29 ng/mL at day 2, respectively. The diagnostic accuracy in our study of uNGAL test at day 1 was 64% and 71% for prediction of AKI presented at days 2 and 3, respectively and of uNGAL at day 2 was 76% and 76% for prediction of AKI presented at days 3 and 4, respectively.
In a prospective study conducted by Mishra et al., they obtained serial urine and serum samples from patients undergoing cardiopulmonary bypass (CPB). They found that, uNGAL concentrations >50 ng/mL reliably predicted AKI in patients at only 2 h following CPB with 100% sensitivity and 98% specificity [27] . Less optimistic results were reported among patients undergoing cardiac surgery, uNGAL levels were consistently higher at 1, 3, 18, and 24 h postoperatively in patients who ultimately developed AKI with best cutoff of 213 ng/mL at 18 h postoperatively (with a sensitivity of 73% and a specificity of 78%) [28] . Also another study conducted by Koyner on adults undergoing elective cardiac surgery showed that uNGAL predicted AKI following cardiac surgery with a sensitivity of 66% and a specificity of 64% and a cutoff at >550 ng/mL [29] . Han et al., reported that uNGAL can be used from the first day of injury as a reliable predictor of early AKI in multi-trauma patients admitted to the ICU. The cutoff point was >25 ng/mL for urinary NGAL with a sensitivity of 91% and a specificity of 95% in prediction of AKI [17] .
Interestingly, these studies performed in adults undergoing cardiac surgery showed that uNGAL was much less sensitive and specific when predicting AKI after complex adult cardiac surgery possibly due to the presence of more chronic kidney disease and co-morbidities in these patients [24, 30] . However, the majority of studies published thus far have involved relatively small numbers of subjects from single centers, in which uNGAL appears to be most sensitive and specific in homogeneous patient populations with predictable forms of AKI [23] . But it is not surprising that the predictive ability of uNGAL for AKI was less in the critically ill population, since the cardiac surgery population represents a much more homogeneous group with a known onset and mechanism of AKI [30] .
The diagnostic characteristics of uNGAL are generally compared against serum creatinine the existing gold standard measure of AKI, although a creatinine-based diagnosis of AKI is itself imperfect potentially contributing to apparent limitations of new biomarkers and for evaluation of the accuracy and the clinical implications of a new test. So, a new biomarker with perfect sensitivity and specificity when compared with serum creatinine would simply replicate the inaccuracies of creatinine [22] .
For the prediction of mortality complicating AKI, in our study the values of uNGAL at day 2 could predict mortality complicating AKI rather than at day 1 (area under curves were 0.65 and 0.86, and P < 0.05 and <0.001, respectively), with the best cutoff value at 32 ng/mL. These results are in agreement with Zappitelli et al., study which showed that the early uNGAL levels were also predictive of duration of AKI in a heterogeneous cohort of critically ill subjects [31] . Also, in another study conducted on patients undergoing cardiac surgery; they found that the 2 h uNGAL levels are highly correlated with length of hospital stay and death [32] .
Limitations
The current study included a relatively small number of patients. It is acknowledged that our results, although of clear clinical and statistical significance, will need to be validated in a larger population.
We used serum creatinine level as a comparator to assess uNGAL performance and to define AKI, which is a bias. Since serum creatinine based detection of AKI is considered somewhat inadequate sought to be replaced by new markers.
The current study design did not allow us to assess whether the test would add to or improve clinical decision making; this would need to be answered in a separate study once the cutoffs are prospectively derived and validated.
Conclusion
A significant increase in uNGAL was observed in ICU patients following circulatory shock. Urinary-NGAL represents a good early predictor biomarker of AKI following circulatory shock and could predict the development of AKI 1-3 days earlier than serum creatinine. Urinary-NGAL at second day following shock could predict mortality complicating AKI.
